SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVNGlobeNewsWire • 07/26/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVNAccesswire • 07/14/24
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar PatientsBusiness Wire • 06/06/24
LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?Zacks Investment Research • 03/21/24
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep ApneaBusiness Wire • 03/20/24
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029Business Wire • 03/06/24
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior NotesBusiness Wire • 03/04/24